[ Price : $8.95]
FDA warns the University of California at San Francisco radiopharmaceutical facility about CGMP violations in its production of fi...[ Price : $8.95]
FDA warns Par USA/Endo USA about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA outlines expanded efforts to reduce animal testing in drug development after reporting significant first-year progress under i...[ Price : $8.95]
President Trump signs an executive order aimed at accelerating the development and availability of psychedelic-based treatments fo...[ Price : $8.95]
FDA accepts for priority review a Pfizer and Astellas Pharma supplemental BLA for Padcev (enfortumab vedotin-ejfv) that seeks to ...[ Price : $8.95]
FDA updates a guidance clarifying how patients, physicians, and drug developers can access investigational therapies outside of cl...[ Price : $8.95]
Nektar Therapeutics reports new 52-week data from its mid-stage REZOLVE-AA trial, showing continued improvement in hair regrowth a...[ Price : $8.95]
FDA tells Passage Bio that a randomized controlled trial will be required to support approval of its experimental gene therapy for...